PMID: 9544767Apr 17, 1998Paper

A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: the INCAS Trial. Italy, The Netherlands, Canada and Australia Study

JAMA : the Journal of the American Medical Association
J S MontanerJ M Lange

Abstract

Current guidelines recommend that individuals infected with the human immunodeficiency virus type 1 (HIV-1) be treated using combinations of antiretroviral agents to achieve sustained suppression of viral replication as measured by the plasma HIV-1 RNA assay, in the hopes of achieving prolonged remission of the disease. However, until recently, many drug combinations have not led to sustained suppression of HIV-1 RNA. To compare the virologic effects of various combinations of nevirapine, didanosine, and zidovudine. Double-blind, controlled, randomized trial. University-affiliated ambulatory research clinics in Italy, the Netherlands, Canada and Australia (INCAS). Antiretroviral therapy-naive adults free of the acquired immunodeficiency syndrome with CD4 cell counts between 0.20 and 0.60x10(9)/L (200-600/microL). Patients received zidovudine plus nevirapine (plus didanosine placebo), zidovudine plus didanosine (plus nevirapine placebo), or zidovudine plus didanosine plus nevirapine. Plasma HIV-1 RNA. Of the 153 enrolled patients, 151 were evaluable. At week 8, plasma HIV-1 RNA levels had decreased by log 2.18, 1.55, and 0.90 in the triple drug therapy, zidovudine plus didanosine, and zidovudine plus nevirapine groups, respectiv...Continue Reading

Citations

Mar 21, 2002·The Lancet Infectious Diseases·Annemarie M C van RossumRonald de Groot
Jan 26, 2002·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·W Sugiura
Nov 30, 2012·AIDS Research and Treatment·Marianne HarrisJulio Montaner
Dec 24, 1998·Lancet·J S MontanerM O'Shaughnessy
Jan 1, 1999·Lancet·A Carr, D A Cooper
Aug 30, 2000·Tropical Medicine & International Health : TM & IH·J Darbyshire
Jan 12, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Mark S SulkowskiRichard D Moore
Feb 3, 1999·Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association·M FloridiaS Vella
Sep 11, 2002·Journal of General Internal Medicine·William C Holmes, Joseph L Pace
Nov 9, 2000·Clinical Pharmacokinetics·M MirochnickA Dorenbaum
Dec 12, 2001·Clinical Pharmacokinetics·P F SmithG D Morse
Jul 27, 1999·Journal of General Internal Medicine·D R Bangsberg, A Moss
Dec 28, 1999·Journal of Urban Health : Bulletin of the New York Academy of Medicine·B GreenbergD Vlahov
Jun 16, 2000·Journal of Urban Health : Bulletin of the New York Academy of Medicine·B GreenbergP A Selwyn
Aug 22, 2000·Antimicrobial Agents and Chemotherapy·L T BachelerK Abremski
Sep 11, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J H ArnstenE E Schoenbaum
Mar 21, 2002·Journal of General Internal Medicine·Loren G MillerNeil S Wenger
Jan 25, 2003·Journal of General Internal Medicine·Kelly A GeboRichard D Moore
Feb 5, 2003·Postgraduate Medical Journal·H K Thaker, M H Snow
Oct 23, 2002·Journal of General Internal Medicine·David R Bangsberg, Steven G Deeks
Oct 24, 2002·British Journal of Clinical Pharmacology·Monique M R de MaatJos H Beijnen
Mar 17, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Alethea W McCormickGeorge R Seage
Sep 21, 2007·European Journal of Clinical Pharmacology·Reinout VriesendorpJacobus Stiekema
Mar 20, 2008·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Gregory S ZaricDouglas K Owens
Jun 19, 2008·Annals of Internal Medicine·Gillian D SandersDouglas K Owens
Feb 19, 2009·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Viviane D LimaJulio S G Montaner

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.